Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


AMA Names New Senior Vice President of Advocacy


 
Todd Askew

The American Medical Association (AMA)announced that Todd Askew has been named as its new Senior Vice President of Advocacy. After serving as AMA's Director of Congressional Affairs for more than 13 years, Askew will now oversee the organization's legislative, government affairs, political, health policy and private sector advocacy activities.

"With his extensive experience in Washington and working within the AMA, Todd Askew will provide strategic leadership that will build upon our successful advocacy on behalf of physicians and their patients to improve the health of the nation," said AMA Chief Executive Officer and Executive Vice President James L. Madara, M.D. "We also thank Rich Deem for dedicating 35 years to the AMA. Under Deem's leadership, the AMA has been instrumental at increasing and protecting access to health coverage for millions of Americans, eliminating the fatally-flawed SGR and making inroads combatting the opioid epidemic."

During his time as AMA's Director of Congressional Affairs, Askew led efforts to advance organized medicine's priorities before the United States Congress. Askew previously served as AMA's Assistant Director of Congressional Affairs.

"I look forward to continuing the AMA's advocacy on behalf of America's physicians to ensure they have the resources and support they need to deliver high quality care to patients," said Askew. "I am eager to continue our efforts to shape the health of the nation by working to reduce dysfunction in the health care system, achieve health equity, train the next generation of physicians and improve public health."

Prior to joining the AMA, Askew served as a legislative aide for the American Academy of Pediatrics Department of Federal Affairs. In this role, he worked extensively on legislative and regulatory matters dealing with health care financing and public health, including the 1997 enactment of the Children's Health Insurance Program (CHIP).

Askew received a B.A. in History from Washington and Lee University in Lexington, VA.

 
Share:

Related Articles:


Recent Articles

Study Finds Certain Genetic Test Not Useful in Predicting Heart Disease Risk

A Polygenic Risk Score -- a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients -- has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.

Read More

Tennessee Infants Exposed to Hep C at Birth Often Not Tested for Virus

Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt Center for Child Health Policy.

Read More

THA, TMA, TNA Outline Legislative Priorities

With the Tennessee General Assembly back in full swing, the state's major healthcare associations outline 2020 priorities.

Read More

Cardiac Innovation in Nashville

From transplants to trials, Nashville hospitals are leading the way in cardiac care.

Read More

A Modern Love Story: Where Technology, Healthcare & Construction Go Hand-in-Hand

Technology has changed every aspect of our lives. In fact, I had a healthy laugh a few weeks ago when I showed my children an old rotary phone and, get this, they did not know what it was.

Read More

Reeves/Smith Bill to Prevent Next Generation of Nicotine Addiction Garners Broad Industry Support

In late January, a group of more than 25 organizations from across Tennessee announced their support for legislation that seeks to prevent the next generation of nicotine addicts in the state.

Read More

Physician Spotlight: A Heart for Healing

TriStar Summit cardiologist Kristen Kerr is passionate about education, improving outcomes in women's heart health.

Read More

Heart Monitor

Read More

Ifetroban for Treating DMD-Associated Cardiomyopathy

Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.

Read More

Endocrine Society Celebrates Progress from Bench to Bedside

Endocrine Society Chief Professional & Clinical Affairs Officer Robert Lash, MD, discusses the field, annual meeting, road shows and more.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: